Spotlight: StemRNA Neuro iPSCs – Human Brain Neurons for Functional Assays

    20 March 2019   Lyndsey McBroom   Stem Cells, iPSCs, Neurite outgrowth assays, Neurons

3D epithelial barrier assays in vitro: How to get the best balance between practicability and physiological relevance

    13 March 2019   Frederique Tholozan   Bio-engineered Tissue Models, REPROCELL Europe, Alvetex, Barrier assays

Using human iPSCs as an in vitro model for regenerative medicine, drug screening and disease modelling

    22 February 2019   Dr Parto Toofan   Drug Discovery, Stem Cells, Primary Cells, iPSCs, Regenerative Medicine

The gut microbiome in health and disease: the future for diagnosis and treatment of IBD and IBS?

    12 February 2019   Dr David Bunton   IBD, Gut Microbiome, Gastrointestinal

Tissue Sourcing for the Development of iPSC-derived Disease Models

    6 February 2019   Dr Sarah Eminli-Meissner   iPSC Reprogramming, Human Tissues, Stem Cells, Primary Cells, iPSCs

Appointment of New Distributor in China

    1 February 2019   Daisuke Usui   Company News

TISSUE SPOTLIGHT: Skin

    5 November 2018   Karen Mcaulay   Drug Discovery, Human Tissues, Tissue Spotlight, Skin

TISSUE SPOTLIGHT: Intestines

    25 October 2018   Karen Mcaulay   Drug Discovery, Human Tissues, Tissue Spotlight, Intestines

The importance of internships for life science students

    19 October 2018   Abbie Wishart   Research & Development, Internship

Press Release: ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

    10 October 2018   Simon Padbury   Stem Cells, Research & Development, Press Release, iPSCs, Clinical Grade, Company News

From Frying-Pan to Fire

    13 September 2018   Zara Puckrin   Research & Development, Government Partnership, Internship

The Human Touch: meeting clinical needs in IBD research

    7 September 2018   Zara Puckrin   Drug Discovery, Human Tissues, Inflammatory Bowel Disease

New publication by Roche on diarrheal toxicity induced by anti-HER2/3 combination therapy includes REPROCELL human fresh tissue data

    26 June 2018   Dr David Bunton   Human Tissues, Ussing Chambers

Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services

    21 June 2018   Chirag Tawde   Drug Discovery, Human Tissues, Primary Cells

Join REPROCELL at ISSCR 2018 in Melbourne, Australia

    15 June 2018   Robert Annand   Stem Cells, ISSCR

REPROCELL’s footprint extends to serve life sciences in India

    13 June 2018   Rama Modali   Human Tissues, Stem Cells, Genome Sequencing, Bioinformatics, Global Expertise

Do animal experiments translate to humans? A report by Elsevier and Bayer uses big data to shed new light on a hotly debated topic

    25 May 2018   Dr David Bunton

Factors to consider when planning a iPSC reprogramming project

    18 May 2018   Dr Sarah Eminli-Meissner   Stem Cells, iPSCs

REPROCELL’s Dr David Bunton on April 2018 Trade Mission to China with Scottish First Minister Nicola Sturgeon

    18 April 2018   Simon Padbury   Company News

Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow

    6 April 2018   Simon Padbury   Company News, REPROCELL Europe

Characterization of iPSCs by Immunocytochemistry

    5 April 2018   Zara Puckrin   Drug Discovery, Stem Cells

The Benefits of Human Tissue to Drug Discovery and Development

    27 March 2018   Karen Mcaulay   Drug Discovery, Human Tissues

REPROCELL’s David Bunton addresses the Scottish Parliament

    21 March 2018   Abbie Wishart   Drug Discovery, Scotland's Economic Performance, Research & Development, Government Partnership, SME

Patient-derived tumor organoids recapitulated clinical treatments

    14 March 2018   Inês A. Silva   Drug Discovery

Five reasons to choose StemRNA 3rd Gen reprogramming

    2 March 2018   Anca Haralambie   iPSC Reprogramming, Drug Discovery, Stem Cells

Inserts or Plates: Which format for your 3D cell culture

    14 February 2018   Frederique Tholozan   Drug Discovery, 3D Cell Culture, Bio-engineered Tissue Models

Cost Effective, Lab-scale iPS Cell Spheroid Culture

    9 February 2018   Robert Annand   3D Cell Culture, Stem Cells

Xeno-free culture of pluripotent stem cells in NutriStem® hPSC XF medium

    5 February 2018   Robert Annand   Drug Discovery, Human Tissues, Stem Cells

REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018

    24 January 2018   Simon Padbury   3D Cell Culture, Bio-engineered Tissue Models

Formation of human tissue to improve drug testing and reduce animal research

    19 January 2018   Simon Padbury   Drug Discovery, Human Tissues, 3D Cell Culture, Bio-engineered Tissue Models

The Power of One Brand

    18 January 2018   Paul Cizdziel   REPROCELL website news

REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

    8 November 2017   Simon Padbury   Company News

Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017

    27 September 2017   Simon Padbury   REPROCELL Europe, Biopta

Nicola Sturgeon: interview at the official opening of REPROCELL’s Centre for Predictive Drug Discovery (YouTube video)

    10 August 2017   Simon Padbury   REPROCELL Europe, Biopta

Press Release: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

    10 August 2017   Simon Padbury   REPROCELL Europe, Biopta

REPROCELL Europe’s CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research

    3 March 2017   Simon Padbury   REPROCELL Europe

REPROCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan

    14 February 2017   Simon Padbury   Company News

Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination

    7 February 2017   Simon Padbury   Company News

Prof Stefan Przyborski to chair the SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb)

    13 January 2017   Simon Padbury   REPROCELL Europe, Alvetex

REPROCELL Europe wins CV Technology Innovator Awards 2016 for Alvetex

    16 September 2016   Simon Padbury   REPROCELL Europe, Alvetex

Prof Stefan Przyborski speaking at BBS 2016 Biennial Meeting

    6 July 2016   Simon Padbury   REPROCELL Europe, Alvetex

REPROCELL Europe’s (formerly Reinnervate’s) CSO Prof Stefan Przyborski to give an Alvetex Seminar at the University of Oxford, 24 May 2016

    20 May 2016   Simon Padbury   REPROCELL Europe, Alvetex

Latest Proteon and Biopta publication demonstrates Proteon's Vonapanitase effects in human cephalic veins

    13 May 2016   Simon Padbury   REPROCELL Europe, Biopta

Proteon and Biopta publication shows promising nonclinical results on Proteon's Vonapanitase

    21 April 2016   Simon Padbury   REPROCELL Europe, Biopta

Reinnervate Ltd wins Corporate Vision’s 2015 Technology Innovator Award for Alvetex

    22 March 2016   Simon Padbury   REPROCELL Europe, Alvetex

Alvetex in Space

    14 January 2016   Simon Padbury   REPROCELL Europe, Alvetex

REPROCELL acquires Biopta to expand its drug discovery services

    25 November 2015   Simon Padbury   REPROCELL Europe, Biopta

Biopta co-authors research in the European Respiratory Journal

    18 November 2015   Simon Padbury   REPROCELL Europe, Biopta

Stemgent, a REPROCELL Group Company Announces a New High Performance Self-replicative RNA Reprogramming Kit

    30 June 2015   Simon Padbury   REPROCELL USA, Stemgent

Alvetex® 3D cell culture platform reaches new heights with project aboard the International Space Station (ISS).

    20 April 2015   Simon Padbury   REPROCELL Europe, Alvetex

New paper demonstrates formation of spontaneously active neuronal networks by stem cell derived neurons in 3D Alvetex Scaffold culture system

    5 March 2015   Simon Padbury   REPROCELL Europe, Alvetex

RSC book publication: "Human-based systems for translational research"

    2 February 2015   Simon Padbury   REPROCELL Europe, Biopta

Biopta and Proteon publish new research in Journal of Cardiovascular Pharmacology

    13 January 2015   Simon Padbury   REPROCELL Europe, Biopta

Alvetex Scaffold 384 well plates used in an Oncology HTS program by AstraZeneca

    8 October 2014   Simon Padbury   REPROCELL Europe, Alvetex

Scottish company creates first searchable database of human pharmacological responses in functional intact tissues

    25 February 2014   Simon Padbury   REPROCELL Europe, Biopta

Launch of Reinnervate Perfusion System for 3D cell culture

    5 February 2014   Simon Padbury   REPROCELL Europe, Alvetex

Biopta collaborates with Merck to investigate in vivo cardiac effects

    13 November 2013   Simon Padbury   REPROCELL Europe, Biopta

Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture

    4 November 2013   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies

    19 September 2013   Simon Padbury   REPROCELL Europe, Alvetex

Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013

    22 August 2013   Simon Padbury   REPROCELL Europe, Alvetex

Alvetex 3D cell culture scaffolds chosen by investigators at Massachusetts General Hospital for study of bone loss during space flight

    31 July 2013   Simon Padbury   REPROCELL Europe, Alvetex

Scottish SMEs Announce Collaboration with Universities, Industry and NHS in Establishment of a £20m Stratified Medicine Scotland Innovation Centre

    23 April 2013   Simon Padbury   REPROCELL Europe, Biopta

3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement

    7 January 2013   Simon Padbury   REPROCELL Europe, Alvetex

3D cell culture firm Reinnervate announce the release of Alvetex®Scaffold 96 well plates for high throughput 3D cell-based assays

    14 December 2012   Simon Padbury   REPROCELL Europe, Alvetex

Medicyte GmbH and Reinnervate Ltd to collaborate on development of next generation predictive 3D cell toxicity assays

    9 July 2012   Simon Padbury   REPROCELL Europe, Alvetex

Top award for 3D cell culture pioneer, Stefan Przyborski, of Reinnervate Ltd

    27 June 2012   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate and Tecan to develop automated 3D cell culture solutions for improved cellular assays

    17 June 2012   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate Ltd and Roslin Cellab announce plans to collaborate

    30 April 2012   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate Ltd announce Kirkstall Ltd collaboration

    30 March 2012   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate and Mirus Bio announce collaboration with the launch of the new 3D Transfection System for the transfection of cells cultured in Alvetex®

    16 November 2011   Simon Padbury   REPROCELL Europe, Alvetex

Alvetex® voted one of most technologically significant new research products by R&D magazine

    27 June 2011   Simon Padbury   REPROCELL Europe, Alvetex

Alvetex® named in the top ten life science innovations of 2010 by The Scientist magazine

    6 December 2010   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate launches Alvetex®, a breakthrough product for enabling routine 3D cell culture

    22 November 2010   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate completes expansion into new purpose-built facility at NETPark

    17 November 2010   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate’s ec23® shown to enhance neuronal differentiation of human fetal neuroprogenitors and human embryonic stem cells

    28 September 2010   Simon Padbury   REPROCELL Europe, Small Molecules

Reinnervate wins Chemistry Innovation / EPSRC Industrial CASE Award to fund development of Alvetex® for the 3D culture of liver cells

    28 September 2010   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate has been accepted as a new member of the In Vitro Testing Industrial Platform (IVTIP)

    14 September 2010   Simon Padbury   REPROCELL Europe, Alvetex

Reinnervate secures £1.8 million of investment to support commercialisation of Alvetex

    27 May 2010   Simon Padbury   REPROCELL Europe, Alvetex